What Are Hyalgan and Synvisc? Hyaluronic acid is a natural, gel-like substance in your joints. It cushions and lubricates your joints as you move them. If you develop OA, cartilage in your joint ...
Feb. 6, 2003 (New Orleans) — In a head-to-head study comparing intra-articular hylan GF-20 injection (Synvisc) to corticosteroid injection for knee osteoarthritis, "there was no difference in outcome ...
Dr. Rob Riley joins us each week from the South Bend Clinic. Here are his responses from October 1st. George: I have rheumatoid arthritis in my knees. My doctor thinks Synvisc might help. How long ...
Biotechnology company Genzyme said Tuesday that U.S. regulators requested additional analyses and data related to its application to have Synvisc-One approved to treat knee pain from osteoarthritis.
Genzyme Corporation today announced that the FDA's Orthopaedic and Rehabilitation Devices Advisory Committee voted unanimously (5 - 0) in favor of approval without conditions of Synvisc-One TM (hylan ...
Synvisc is contraindicated in patients with known hypersensitivity to hyaluronan products and in patients with infections in or around the target knee. Do not inject Synvisc extra-articularly, into ...
Synvisc-One (hylan G-F 20, from Genzyme), has been FDAapproved for the relief of pain associated with osteoarthritis (OA) of the kneein patients who have failed to respond adequately to ...
osteoarthritis pain drug Synvisc from Wyeth. The transaction is expected to close in January. Under the terms of the agreement, Genzyme will pay Wyeth up-front payments of $121 million in cash for the ...
To earn CME related to this news article, click here. March 5, 2009 — The US Food and Drug Administration (FDA) has approved budesonide plus formoterol fumarate dihydrate inhalation aerosol for the ...
BOSTON (MarketWatch) -- Genzyme Corp. said early Monday that it plans to challenge a decision by the Centers for Medicare and Medicaid Services to change the reimbursement process for its product ...
Important Therapy Provides Six Months Pain Relief with Single Injection Genzyme Corporation (Nasdaq: GENZ) today announced that the U.S. Food and Drug Administration (FDA) has granted marketing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results